BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19169967)

  • 1. Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study.
    Bertrand E; Lewandowska E; Stepień T; Szpak GM; Pasennik E; Modzelewska J
    Folia Neuropathol; 2008; 46(4):255-70. PubMed ID: 19169967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies.
    Szpak GM; Lewandowska E; Wierzba-Bobrowicz T; Bertrand E; Pasennik E; Mendel T; Stepień T; Leszczyńska A; Rafałowska J
    Folia Neuropathol; 2007; 45(4):192-204. PubMed ID: 18176893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
    van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
    Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
    Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral beta-amyloid angiopathy in aged squirrel monkeys.
    Elfenbein HA; Rosen RF; Stephens SL; Switzer RC; Smith Y; Pare J; Mehta PD; Warzok R; Walker LC
    Histol Histopathol; 2007 Feb; 22(2):155-67. PubMed ID: 17149688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report].
    Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T
    Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid angiopathy in diffuse Lewy body disease.
    Wu E; Lipton RB; Dickson DW
    Neurology; 1992 Nov; 42(11):2131-5. PubMed ID: 1436523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.